Related Targets
|
Mechanism
α-adrenergic receptor agonists
[+1]
|
Active Org.
|
Originator Org.
|
Active Indication
|
Inactive Indication
-
|
Drug Highest Phase
Approved
|
First Approval Ctry. / Loc.
US
|
First Approval Date
29 Apr 2016
|
Mechanism
α-adrenergic receptor antagonists
[+1]
|
Originator Org.
|
Active Indication
|
Inactive Indication
-
|
Drug Highest Phase
Approved
|
First Approval Ctry. / Loc.
US
|
First Approval Date
20 Oct 2006
|
Mechanism
mAChRs agonists
[+2]
|
Active Org.
|
Originator Org.
|
Active Indication
|
Inactive Indication
-
|
Drug Highest Phase
Approved
|
First Approval Ctry. / Loc.
RU
|
First Approval Date
01 May 2006
|
Start Date
07 Dec 2023
|
Sponsor / Collaborator
|
Start Date
27 Oct 2023
|
Sponsor / Collaborator
|
Start Date
03 Oct 2023
|
Sponsor / Collaborator
|